SYNLAB provides laboratory diagnostic services and specialty testing in Europe, self-described as a leader in the field.

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.

COM:SYNLAB

SYNLAB

Last Close

11.06

12/07 15:35

Market Cap

2.42B

Beta: -

Volume Today

140.35K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics